Ltd., Asterion Ltd, CIMAB S.A., Prolong Pharmaceuticals, Acceleron Pharma, Inc.,
SynZyme Technologies, LLC, Pieris AG, Xenon Pharmaceuticals Inc., ERYtech Pharma, Archemix Corp., HemaQuest Pharmaceuticals, Inc., Akebia Therapeutics, Inc., GENETIX Pharmaceuticals, Inc., NOXXON Pharma AG, Morphogenesis, Inc., NKT Therapeutics, Inc., Bolder Biotechnology, Inc., Palkion, Inc., Acetylon Pharmaceuticals, Inc., Emmaus Medical, Inc., Avesthagen Limited, PharmaEssentia Corporation, Vifor Pharma Ltd., AesRx, LLC., Errant Gene Therapeutics, LLC, NAL Pharmaceuticals Ltd.
Taking another tack, researchers at
SynZyme in Irvine, Calif., are trying to add more functions of whole red blood cells to hemoglobin products.